Stay updated on Teclistamab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab in Multiple Myeloma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0, with no change to the study record details.SummaryDifference0.0%

- Check21 days agoChange DetectedA site-wide NIH banner announces updates related to the agency’s transition from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.3%

- Check28 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check35 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check56 days agoChange DetectedNew Revision: v3.7.0 appears in the history. The previous Revision: v3.6.6 is no longer shown in the list.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page shows Revision: v3.6.6, replacing the previous v3.6.5 in the history. This represents a small update to the page's revision record.SummaryDifference0.0%

Stay in the know with updates to Teclistamab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab in Multiple Myeloma Clinical Trial page.